Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Ruxolitinib can cause a delayed skin reaction on the nose.

New molecules can prevent cell death in hair follicles.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Allopurinol may cause rare granulomatous microscopic colitis.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Finasteride and flutamide can effectively treat hirsutism, with abdominal hairs showing the most sensitivity to the treatment.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Pulsed electric field treatment may help shrink untreated liver tumors.

The rash resolved after stopping ponatinib.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Wnt-activating drugs generally do not increase cancer risk.

5-aminosalicylic acid enemas may cause hair loss.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

New compounds were made that are promising for prostate cancer therapy.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.